Title:
多価かつ多重特異性の４１ＢＢ結合融合タンパク質
Document Type and Number:
Japanese Patent JP7022993
Kind Code:
B2
Abstract:
This invention relates generally to molecules that specifically engage 41BB, a member of the TNF receptor superfamily (TNFRSF). More specifically, this invention relates to multivalent and multispecific molecules that bind at least 41BB.
Inventors:
Eckelman Brendan Pee.
Timmer John Sea.
Grouper Chelsea
Jones Kyle S.
Hussein Abrahim
Razai Amir S.
Beckland Brian
Pandit Rajay
Kaplan Mike
Rayson Lucas
Devrow Quinn
Timmer John Sea.
Grouper Chelsea
Jones Kyle S.
Hussein Abrahim
Razai Amir S.
Beckland Brian
Pandit Rajay
Kaplan Mike
Rayson Lucas
Devrow Quinn
Application Number:
JP2018535301A
Publication Date:
February 21, 2022
Filing Date:
January 11, 2017
Export Citation:
Assignee:
Inhiburgs Incorporated
International Classes:
C07K16/28; A61K39/395; A61K47/68; A61P29/00; A61P35/00; A61P37/04; A61P43/00; C07K16/18; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10
Foreign References:
| US20140242077 | ||||
| US8337850 | ||||
| US20150190506 | ||||
| WO2018115003A2 | ||||
| WO2014028776A1 |
Other References:
Clin Cancer Res, 2013, 19(5), pp.1054-1062
Cancer Immunol Res, 2015, 3(2), pp.149-160
Cancer Immunol Res, 2015, 3(2), pp.149-160
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office
Previous Patent: Pachinko machine
Next Patent: How to treat eye inflammation and chemical damage to the eye with extracellular vesicles
Next Patent: How to treat eye inflammation and chemical damage to the eye with extracellular vesicles